Count | |
| 75 | |
| 29 | |
| 1 | |
| 4 | |
| 1 | |
| 7 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 4 | |
Antilipemic Agents/pharmacokinetics/*pharmacology/*therapeutic use | 1 |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
Antilipemic Agents/*administration & dosage/pharmacology/therapeutic use | 1 |
Antilipemic Agents/adverse effects/*pharmacokinetics/therapeutic use | 1 |
| 2 | |
| 1 | |
| 14 | |
| 37 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 14 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
Antilipemic Agents/*chemical synthesis/chemistry/pharmacology | 1 |
Antilipemic Agents/adverse effects/metabolism/pharmacokinetics | 1 |
Antilipemic Agents/blood/chemistry/*metabolism/pharmacokinetics | 1 |
Antilipemic Agents/*chemical synthesis/pharmacokinetics/pharmacology | 1 |
| 1 | |
Antilipemic Agents/administration & dosage/pharmacokinetics/*pharmacology | 1 |
| 1 | |
| 1 | |
| 13 | |
| 131 | |
| 7 | |
| 1 | |
| 3 | |
| 29 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 9 | |
| 52 | |
| 2 | |
| 3 | |
| 6 | |
| 2 | |
| 221 | |
| 15 | |
| 3 | |
| 203 | |
| 1 | |
| 3 | |
| 2 | |
| 30 | |
| 2 | |
| 29 | |
| 2 | |
| 11 | |
| 1 | |
| 3 | |
| 1 | |
| 29 | |
| 1 | |
| 104 | |
| 4 | |
| 228 | |
| 1 | |
| 2 | |
| 2 | |
| 43 | |
| 2 | |
| 2 | |
| 4 | |
| 12 | |
| 1 | |
| 9 | |
| 18 | |
| 24 | |
| 19 | |
| 19 | |
| 6 | |
| 32 | |
| 9 | |
| 10 | |
| 5 | |
| 24 | |